157 related articles for article (PubMed ID: 9826888)
1. Meloxicam in acute UV dermatitis--a pilot study.
Bayerl C; Pagung R; Jung EG
Photodermatol Photoimmunol Photomed; 1998; 14(5-6):167-9. PubMed ID: 9826888
[TBL] [Abstract][Full Text] [Related]
2. Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study.
Altman R; Luciardi HL; Muntaner J; Del Rio F; Berman SG; Lopez R; Gonzalez C
Circulation; 2002 Jul; 106(2):191-5. PubMed ID: 12105157
[TBL] [Abstract][Full Text] [Related]
3. Meloxicam: selective COX-2 inhibition in clinical practice.
Furst DE
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
[TBL] [Abstract][Full Text] [Related]
5. Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population.
Smith HS; Baird W
Am J Hosp Palliat Care; 2003; 20(4):297-306. PubMed ID: 12911075
[TBL] [Abstract][Full Text] [Related]
6. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis.
Knijff-Dutmer EA; Kalsbeek-Batenburg EM; Koerts J; van de Laar MA
Rheumatology (Oxford); 2002 Apr; 41(4):458-61. PubMed ID: 11961179
[TBL] [Abstract][Full Text] [Related]
7. Meloxicam in rheumatoid arthritis.
Ahmed M; Khanna D; Furst DE
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):739-51. PubMed ID: 16863437
[TBL] [Abstract][Full Text] [Related]
8. Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam.
Curtiss FR
J Manag Care Pharm; 2006 Apr; 12(3):265-8. PubMed ID: 16623613
[No Abstract] [Full Text] [Related]
9. [Meloxicam--the balance of efficacy and safety].
Morović-Vergles J
Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
[TBL] [Abstract][Full Text] [Related]
10. [The selective cox-2 inhibitor meloxicam and salicylate therapy].
Tóth K
Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964
[TBL] [Abstract][Full Text] [Related]
11. Relative safety of meloxicam in NSAID-intolerant patients.
Kosnik M; Music E; Matjaz F; Suskovic S
Allergy; 1998 Dec; 53(12):1231-3. PubMed ID: 9930610
[No Abstract] [Full Text] [Related]
12. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
13. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M
J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effect of meloxicam in canine acute dermatitis--a pilot study.
Viking Höglund O; Frendin J
Acta Vet Scand; 2002; 43(4):247-52. PubMed ID: 12831177
[TBL] [Abstract][Full Text] [Related]
15. Meloxicam.
Fleischmann R; Iqbal I; Slobodin G
Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
[TBL] [Abstract][Full Text] [Related]
16. The non-steroidal anti-inflammatory drugs protect mouse cochlea against acoustic injury.
Hoshino T; Tabuchi K; Hirose Y; Uemaetomari I; Murashita H; Tobita T; Hara A
Tohoku J Exp Med; 2008 Sep; 216(1):53-9. PubMed ID: 18719338
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
Degner F; Sigmund R; Zeidler H
Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
[TBL] [Abstract][Full Text] [Related]
18. [Meloxicam].
Sternon J; Appelboom T
Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
[TBL] [Abstract][Full Text] [Related]
19. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study.
Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z
Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059
[TBL] [Abstract][Full Text] [Related]
20. [Meloxicam (Movalis)].
Kaliterna DM
Reumatizam; 2007; 54(2):81-2. PubMed ID: 18351150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
